International Stereotactic Radiotherapy Symposium October 19-20, 2013 Call for Abstracts Submission Deadline Friday, September 20, 2013 MD Anderson Cancer Center, Dan L. Duncan Building (CPB) Floor 8 Conference Center, 1155 Pressler Street, Houston, Texas
12
Embed
International Stereotactic Radiotherapy Symposium International_Stereotactic... · International Stereotactic Radiotherapy Symposium October 19-20, 2013 Call for Abstracts Submission
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
International Stereotactic Radiotherapy Symposium
October 19-20, 2013
Call for AbstractsSubmission Deadline
Friday, September 20, 2013
MD Anderson Cancer Center, Dan L. Duncan Building (CPB)Floor 8 Conference Center, 1155 Pressler Street, Houston, Texas
GoalThis international symposium will focus on providing updated information about the roles of stereotactic radiotherapy including stereotactic radiosurgery and stereotactic body radiation therapy in the management of cancers. Many of the presentations are geared towards cutting-edge technology, updated clinical data/protocols and sources of controversy. The practitioners attending this symposium will obtain current knowledge about indications, techniques, controversies and future research directions using stereotactic radiotherapy. Our symposium is intended to improve practitioner knowledge and performance, clinical management, and research.
Educational ObjectivesAfter attending this conference, participants should be able to•Interprettheevolvingclinicalindicationsandpatientselectioncriteriaforstereotactic
grade 3 and above pneumonitis, hemoptysis, fistulae, chest wall pain, rib fracture, neuropathy and the approaches to minimize them (Knowledge, Competence);
•Implementthecutting-edgetechnologyusedtomanagetumormotionand optimize stereotactic radiotherapy design and delivery to improve patient care (Knowledge, Competence, Performance, Patient Outcomes);
•Explorenovelconceptsofcombiningstereotacticradiotherapywithimmune and/or molecular target therapy in locally advanced and metastatic cancers (Knowledge, Competence); and
EvaluationA course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.
Accreditation/Credit Designation•Physicians: TheUniversityofTexasMDAndersonCancerCenterisaccreditedbytheAccreditationCouncilforContinuingMedicalEducationtoprovidecontinuingmedicaleducation for physicians.
TheUniversityofTexasMDAndersonCancerCenterdesignatesthisliveactivityforamaximumof9.50AMA PRA Category 1 Credits TM. Physicians should claim only credit commensuratewiththeextentoftheirparticipationintheactivity.
•Radiologic Technologist Credits: Pending approval by the America Society of Radiologic Technologists (ASRT) for Category A continuing education credit.
CME Certificates and Attendance Verification CertificatesCertificates awarding AMA PRA Category 1 Credit TM or certificates documenting attendance will be distributed to participants when an individual departs the conference. ToobtainaCMEcertificate,physiciansmustsubmitacompletedevaluationquestionnaire and a CME Verification Form.
Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.
Call for AbstractsAbstracts for the Poster Session may be submitted to Ms. Dana Garrison, e-mail: [email protected]; Tel: 713-563-2364. Early submissions are stronglhy encouraged. Physicians, Physicists, biologists, dosimetrists, fellows, trainees, postdoctoral, nurses and other health care professionals are encouraged to submit abstracts for poster presentations for the InternationalStereotacticRadiotherapySymposiumconferenceforhealthcareprofessionals.
Abstracts will be accepted for the following categories:1. Clinicalprojectsrelatedtostereotacticradiosurgeryorstereotacticbodyradiotherapy2. Physicsandplanningprojectsrelatedtoplanningoptimization,qualityassuranceand
delivery of stereotactic radiotherapy3. Biological studies related to hypofractionated radiotherapy, immunotherapy and
target therapy
Abstract InstructionsAbstracts will be screened for relevance to stereotactic radiotherapy optimization, novel technologies, quality assurance, image-guided delivery, combination with biological treatment and biological mechanisms. Structure abstracts using the following mandatory format:•PurposeorBackground,Methods,Results,andConclusions. Ifnotapplicabletoyourabstract,makeanoteofitintheappropriatesectionoftheabstract.•Theentireabstract(titleandbody)mustnotexceed2,000characters(notincludingspaces),whichisapproximately300-350words.
Submission InstructionsPlease include the name of the conference, title of your presentation, author’s full name, highest degree, mailing address, and institutional affiliation. Also, please include author’s telephone,fax,ande-mailinformation.Theconferenceexecutivecommitteewillselectabstracts for poster and/or possible oral presentation on the basis of their scientific merit andcontentquality.Ifselected,youwillreceiveaconfirmationletterwithdetailed information about the poster session. The content of the abstracts will not be edited. Freestanding4’x8’displayboardswillbeprovidedfordisplayingposters.Certificationofyour presentation will be issued if your abstract is selected to present.
Deadline for abstract submissions is Friday, September 20, 2013.
Saturday Oct. 19, 2013 Morning Session: SABR In NSCLC7:00am RegistrationandContinentalBreakfast
8:30 Welcome ThomasBuchholz,MD
8:40 Stereotactic Ablative Radiotherapy: Past, Current and Future RobertTimmerman,MD
9:05 Stereotactic Ablative Radiotherapy: Aim for a Potential Cure in Recurrent, Multi Primary Early Stage NSCLC
JoeY.Chang,MD,PhD
9:30 Debuts and Challenges of Lung Cancer Screen MyrnaGodoy,MD
9:55 BreakandPosterPresentations
10:30 Debate: Surgery or SABR in Borderline or Operable Stage I NSCLC
JackA.Roth,MD RobertTimmerman,MD
10:55 Centrally Located Lung Lesions: Is This a No Fly Zone for SABR AndreaBezjak,MD JoeY.Chang,MD,PhD
11:20 Stereotactic Radiotherapy in Locally Advanced NSCLC: A Novel Way for Dose Escalation/Acceleration
RonaldCharlesMcGarry,MD,PhD
11:45 Ask the Experts
12:00pm Lunch(provided)andPosterPresentations
Program
Afternoon Session: SABR in Locally Advanced/Metastatic Diseases and Other Disease Sites
1:30 Role of Ablative Local Therapy in Oligo-metastatic Diseases BrianKavanagh,MD,MPH
1:55 Stereotactic Ablative Radiotherapy in Primary and Metastatic Liver Cancer
BrianKavanagh,MD,MPH
2:20 Debate: Stereotactic vs. IMRT in Pancreatic Cancer ChristopherCrane,MD JosephMichaelHerman,MD
2:45 BreakandPosterPresentations
3:10 Debate: Re-irradiation for Head and Neck Malignancies: Stereotactic vs. IMRT/IMPT in Head and Neck Disease
FarzanSiddiqui,MD,PhD StevenFrank,MD
3:35 Debate: SABR vs. Surgery in Spinal Metastasis LaurenceRhines,MD EricChang,MD
4:00 SBRT: Are More Than the 5 R’s of Radiobiology Involved? J.MartinBrown,PhD
4:25 Ask the Experts
4:40 Best Poster Presentations
5:05 Adjourn
Sunday Oct. 20, 2013 Morning Session: Radiosurgery/SABR in Intracranial/
Spine Lesions and Cutting-edge Technologies
8:00am RegistrationandContinentalBreakfast
8:30 Intracranial Radiosurgery: Indications, Evaluation and Controversy
PaulBrown,MD
8:55 SABR for Spine: Indications, Evaluation and Controversy EricChang,MD
9:20 Debate: Surgery vs. Radiosurgery for Isolated Brain Lesion JeffreyWeinberg,MD PaulBrown,MD
9:45 Radiation Necrosis After Cranial SRS CarolineChung,MD
10:10 Combining Systemic Therapy with Cranial SRS CarolineChung,MD
10:35 Break
10:45 Stereotactic Radiotherapy in Genitourinary Malignancies BinTeh,MD
11:10 Cutting-edge Strategies of SABR in Moving Target: Planning, Quality Assurance and Delivery
PeterBalter,PhD
11:35 Gamma-knife vs. Linear Accelerator Based Radiosurgery: Planning and Treatment Delivery
JamesYang,PhD
12:00 Ask the Experts
12:15pm Adjourn
MD Anderson FacultyPeter Balter, PhDAssociate ProfessorRadiation Oncology – Physics Patient Care
Paul Brown, MDProfessorRadiation Oncology
Thomas Buchholz, MDProvost&EVPAdInterimProvostandEVP
Joe Y. Chang, MD, PhDProfessorRadiation Oncology
Christopher Crane, MDProfessorRadiation Oncology
Steven Frank, MDAssociate ProfessorRadiation Oncology
Advance registration is encouraged as space and materials are limited. Please see the registration form for applicable fees.
The deadline for advance registration is Friday, October 4, 2013.
There are three ways to register:•By Mail:MailtoDepartmentofCME/ConferenceManagement,Unit1381, TheUniversityofTexasMDAndersonCancerCenter,P.O.Box301439, Houston,TX77230-1439
•By Fax:Faxto713-794-1724•On-line: Register On-line at www.mdanderson.org/conferences
Telephone registrations are not accepted.
We accept the following forms of payment:•Check(payablethroughU.S.banksonly)•Moneyorder•Creditcards(MasterCard,VISA,andAmericanExpress)•Cash(on-siteregistrationonly)
When registering online a receipt/confirmation letter will be automatically emailed to theemailaddressyoulistontheregistrationform.Ifyouregisterbyfaxormailareceipt/confirmation letter will be sent to you within ten working days of receipt of your fee.
Theconferenceregistrationfeeincludesthetuition,CMEfinalprogrampages,CD, breakfasts, lunches and breaks.
Refund/Cancellation Policy Theregistrationfee,minusa$50administrativehandlingfee,isrefundableifawrittenrequestisreceivedonorbeforeFriday,October4,2013.NorefundswillbegrantedafterOctober4.Therequestforaregistrationrefundmustincludethetaxidentificationnumber of the company or institution if registration was paid by a company or institution check. Foradditionalinformation,contactCME/ConferenceManagementat713-792-2223ortollfreeat866-849-5866.
TheDepartmentofCME/ConferenceManagementreservestherighttocancelactivities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Eachregistrantwillbenotifiedbymail,e-mail,oratthephoneorfaxnumbersgivenon the registration form.
Incaseofactivitycancellation,theliabilityoftheDepartmentofCME/ConferenceManagementislimitedtotheregistrationfee.CME/ConferenceManagementwill refund the full registration fee.
TheDepartmentofCME/ConferenceManagementreservestherighttolimitthenumberofparticipantsinaprogramandisnotresponsibleforanyexpensesincurredbyanindividualwhose registration is not confirmed and for whom space is not available.
Please let us know what specific topics, issues, or questions you wish to see addressed or emphasizedinthisactivity.Faxore-mailCME/ConferenceManagement.Allresponseswillbeforwarded to the Program Chair for consideration.
TheUniversityofTexasMDAndersonCancerCenterhasimplementedaprocesswhereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the informationpresented.MDAndersonalsorequiresthatallfacultydiscloseanyunlabeleduseor investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.
Agendasaresubjecttochangebecausewearealwaysstrivingtoimprovethequalityofyoureducationalexperience.MDAndersonmaysubstitutefacultywithcomparableexpertiseon rare occasions necessitated by illness, scheduling conflicts, and so forth.
Photographing, audio taping, and videotaping are prohibited.
Special Assistance ContacttheDepartmentofCME/ConferenceManagementat713-792-2223ortollfree at866-849-5866ifyouhaveanyspecialdietaryorADAaccommodationneeds.
Accommodations•AblockofroomshasbeenreservedforconferenceattendeesattheJesse H. Jones
Rotary House International, 1600HolcombeBoulevard,Houston,Texas.•Earlyhotelreservationissuggested.•TheJesseH.JonesRotaryHousephonenumbersare713-790-1600and1-800-847-5783.•Whenyoumakereservations,besuretomentiontheStereotactic Radiotherapy
Symposium, Client Code: CONFE2 to be assured of receiving the special meeting rate of$115.00Kingoccupancy,$125Kingoccupancywithkitchenette,$121.00Double Queenoccupancyand$134.00DoubleQueenoccupancywithkitchenette.Pleaseadd17%(Texas)stateandlocaltaxes.
•ReservationsanddepositsreceivedafterSaturday, October 5, 2013 will be confirmed if space is available and at current hotel published guest room rates.